900,000 Shares in Medline $MDLN Acquired by National Pension Service

National Pension Service acquired a new position in shares of Medline (NASDAQ:MDLNFree Report) in the 4th quarter, Holdings Channel.com reports. The fund acquired 900,000 shares of the company’s stock, valued at approximately $37,800,000.

Other institutional investors have also recently modified their holdings of the company. Sound Income Strategies LLC acquired a new position in shares of Medline during the 4th quarter worth approximately $25,000. Entrust Financial LLC acquired a new position in shares of Medline during the 4th quarter worth approximately $26,000. NBC Securities Inc. acquired a new position in shares of Medline during the 4th quarter worth approximately $28,000. Global Retirement Partners LLC acquired a new position in shares of Medline during the 4th quarter worth approximately $31,000. Finally, North Star Investment Management Corp. acquired a new position in shares of Medline during the 4th quarter worth approximately $36,000.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on MDLN. UBS Group lifted their price objective on Medline from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Thursday, February 26th. Citigroup cut their price target on Medline from $60.00 to $55.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Evercore reiterated an “outperform” rating and issued a $55.00 price target on shares of Medline in a report on Wednesday, February 25th. Leerink Partners set a $56.00 price target on Medline in a report on Wednesday, February 25th. Finally, Sanford C. Bernstein cut their price target on Medline from $56.00 to $54.00 and set an “outperform” rating for the company in a report on Thursday, May 7th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $50.85.

Get Our Latest Stock Report on Medline

Medline Price Performance

Shares of MDLN opened at $36.56 on Monday. The company has a fifty day simple moving average of $42.30. Medline has a fifty-two week low of $34.89 and a fifty-two week high of $50.88.

Medline (NASDAQ:MDLNGet Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.04. The business had revenue of $7.35 billion during the quarter. Medline’s quarterly revenue was up 10.7% compared to the same quarter last year. On average, analysts forecast that Medline will post 1.5 EPS for the current year.

Medline Company Profile

(Free Report)

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply?chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.

Read More

Want to see what other hedge funds are holding MDLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medline (NASDAQ:MDLNFree Report).

Institutional Ownership by Quarter for Medline (NASDAQ:MDLN)

Receive News & Ratings for Medline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medline and related companies with MarketBeat.com's FREE daily email newsletter.